Femasys Inc.
- FEMY
- NASDAQ
- Medical - Instruments & Supplies
- Women's Health/Contraceptives
- Medical Devices (Reproductive)
- Fertility
$1.66
Today −0.60%Quote Oct 21, 2026, 03:09 PM UTC
−33.99%over the last month
Max drawdown −39.5%From 1-month high −35.3%3 months −52.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Femasys
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Employees
53
Market value
$13.9M
Quote Oct 21
Floor
$1.46
12.0% below price
Resistance
$1.71
3.0% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about FEMYPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free